Biotech Investors & VC Firms in Paris
32 firms in this list, with a median first check of $820K. 10 of them lead rounds. Generated from verified public data and updated continuously.
Xerys
ParisSeed–Late Stage$16M – $97M
Extens
ParisSeries A–Series B$3.2M – $16.2M
2 people
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
Wilco
ParisPre-Seed–Seed$55K – $108K
Cathay Health
San FranciscoSeed–Late Stage
1 person
Turenne Capital Partenaires
ParisGrowth
UI Investissement
ParisPre-Seed–Seed
Good Only Ventures
ParisSeed–Series A
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.
